SFX by Ex Libris Inc.

Title:	Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene
Source:	Human Molecular Genetics [0964-6906] Mahadevan, Mani yr:1993

Basic

Full text

Full text available via Oxford University Press Journals Digital Archive Legacy

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Roy, N. "The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy." Cell 80.1 (1994): 167-78.
description	2.	Ogino, S. "Genetic testing and risk assessment for spinal muscular atrophy (SMA)." Human genetics 111.6 (2003): 477-500.
description	3.	Coulson, A H D. "The survival motor neuron protein in spinal muscular atrophy." Human molecular genetics 6.8 (1997): 1205-14.
description	4.	Korneluk, R G G. "Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes." Nature 379.6563 (1995): 349-53.
description	5.	Ferreiro, A. "Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies." American journal of human genetics 71.4 (2002): 739-49.
description	6.	Salvesen, Guy S S. "IAP proteins: blocking the road to death's door." Nature reviews. Molecular cell biology 3.6 (2002): 401-10.
description	7.	Moghadaszadeh, B. "Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome." Nature genetics 29.1 (2001): 17-8.
description	8.	Ogino, S. "Bayesian analysis and risk assessment in genetic counseling and testing." The journal of molecular diagnostics 6.1 (2004): 1-9.
description	9.	Wilson, Robert B B. "Genetic risk assessment in carrier testing for spinal muscular atrophy." American journal of medical genetics 110.4 (2002): 301-7.
description	10.	Smith, M. "Population screening and cascade testing for carriers of SMA." European journal of human genetics 15.7 (2007): 759-66.
description	11.	Emery, A E E. "Population frequencies of inherited neuromuscular diseases--a world survey." Neuromuscular Disorders 1.1 (1991): 19-29.
description	12.	Prasad, Asuri N N. "The floppy infant: contribution of genetic and metabolic disorders." Brain & development 25.7 (2003): 457-76.
description	13.	Scott, Guy S L. "XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs." The EMBO journal 24.3 (2005): 645-55.
description	14.	Salvesen, Guy S S. "The nematode death machine in 3D." Cell 123.2 (2005): 192-3.
description	15.	Liuwantara D, Elliot M, Smith MW, Yam AO, Walters, Shane T T. "Nuclear Factor-{kappa}B Regulates {beta}-Cell Death: A Critical Role for A20 in {beta}-Cell Protection." Diabetes 55.9: 2491-501.
description	16.	Mailman, Thomas D. "Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2." Genetics in medicine 4.1 (2002): 20-6.
description	17.	Xia, Y. "Effectiveness of selenium supplements in a low-selenium area of China." The American journal of clinical nutrition 81.4 (2005): 829-34.
description	18.	Desbarats, J. "Fas engagement induces neurite growth through ERK activation and p35 upregulation." Nature cell biology 5.2 (2003): 118-25.
description	19.	Monani, A H R. "Animal models of spinal muscular atrophy." Human molecular genetics 9.16 (2000): 2451-2457.
description	20.	Hsieh-Li, H M M. "A mouse model for spinal muscular atrophy." Nature genetics 24.1 (1999): 66-70.